Versant Venture Management, LLC
San Francisco CA · SEC CIK 0001560009
$1.41亿2026Q1 申报市值
8持仓数
100.0%前十大占比 · 第一大 37.0%
1 / 0新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▲ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| — | Tempest Therapeutics, Inc. | $44.24万 | 0.31% | 269,772 | 0 | 0.0% | — | 不变 |
| — | Skye Bioscience, Inc. | $123.39万 | 0.87% | 2,007,704 | 0 | 0.0% | — | 不变 |
| CRSP | CRISPR Therapeutics AG | $707.99万 | 5.01% | 148,831 | 0 | 0.0% | — | 不变 |
| CTNM | Contineum Therapeutics, Inc. | $708.67万 | 5.01% | 542,628 | 0 | 0.0% | — | 不变 |
| JBIO | Jade Biosciences, Inc. | $2,143.78万 | 15.16% | 1,525,820 | 0 | 0.0% | — | 不变 |
| LENZ | Lenz Therapeutics, Inc. | $2,431.05万 | 17.19% | 2,656,888 | 0 | 0.0% | — | 不变 |
| IPSC | Century Therapeutics, Inc. | $2,749.54万 | 19.44% | 12,166,109 | 12,166,109 | — | $2,749.54万 | 新建仓 |
| GLUE | Monte Rosa Therapeutics, Inc. | $5,232.38万 | 37.00% | 3,180,780 | -1,201,907 | -27.4% | -$1,977.14万 | 减仓 |